1. Home
  2. CORZ vs NUVL Comparison

CORZ vs NUVL Comparison

Compare CORZ & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORZ
  • NUVL
  • Stock Information
  • Founded
  • CORZ 2017
  • NUVL 2017
  • Country
  • CORZ United States
  • NUVL United States
  • Employees
  • CORZ N/A
  • NUVL N/A
  • Industry
  • CORZ
  • NUVL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CORZ
  • NUVL Health Care
  • Exchange
  • CORZ NYSE
  • NUVL Nasdaq
  • Market Cap
  • CORZ 5.0B
  • NUVL 4.9B
  • IPO Year
  • CORZ N/A
  • NUVL 2021
  • Fundamental
  • Price
  • CORZ $17.55
  • NUVL $92.73
  • Analyst Decision
  • CORZ Strong Buy
  • NUVL Strong Buy
  • Analyst Count
  • CORZ 12
  • NUVL 10
  • Target Price
  • CORZ $18.58
  • NUVL $112.60
  • AVG Volume (30 Days)
  • CORZ 10.9M
  • NUVL 457.4K
  • Earning Date
  • CORZ 11-06-2024
  • NUVL 11-12-2024
  • Dividend Yield
  • CORZ N/A
  • NUVL N/A
  • EPS Growth
  • CORZ N/A
  • NUVL N/A
  • EPS
  • CORZ N/A
  • NUVL N/A
  • Revenue
  • CORZ $557,676,000.00
  • NUVL N/A
  • Revenue This Year
  • CORZ $8.48
  • NUVL N/A
  • Revenue Next Year
  • CORZ $24.71
  • NUVL N/A
  • P/E Ratio
  • CORZ N/A
  • NUVL N/A
  • Revenue Growth
  • CORZ 15.77
  • NUVL N/A
  • 52 Week Low
  • CORZ $2.61
  • NUVL $61.02
  • 52 Week High
  • CORZ $18.35
  • NUVL $113.51
  • Technical
  • Relative Strength Index (RSI)
  • CORZ 67.88
  • NUVL 49.58
  • Support Level
  • CORZ $15.33
  • NUVL $85.38
  • Resistance Level
  • CORZ $17.38
  • NUVL $96.24
  • Average True Range (ATR)
  • CORZ 1.11
  • NUVL 3.17
  • MACD
  • CORZ 0.12
  • NUVL 0.18
  • Stochastic Oscillator
  • CORZ 86.30
  • NUVL 66.70

About CORZ CORE SCIENTIFIC INC

Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: